Aarti Drugs Standalone June 2021 Net Sales at Rs 505.79 crore, up 6.36% Y-o-Y
NULL28-07-2021
Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached herewith press release on the Financial Results for the quarter ended June 30, 2021.27-07-2021
Aarti Drugs Ltd - 524348 - Regulation 30 And 31A(8) Of The Listing Regulations.
Re-classification of Shareholding from 'Promoter Group' category to 'Public' category in accordance with Regulation 31A of the SEBI (LODR) Regulations, 2015 ('Listing Regulations').27-07-2021
Aarti Drugs Ltd - 524348 - Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2021.
We wish to inform you that Board of Directors at its Meeting held on Tuesday, July 27, 2021, approved the Audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2021.27-07-2021
AARTI DRUGS LTD. - 524348 - Intimation Regarding Receipt Of A Request From The Member Of Promoter Group Of The Company Seeking Re-Classification From 'Promoter Group' Category To 'Public' Category In Accordance With Regulation 31A Of The SEBI (LODR) Regulations, 2015 ('Listing Regulations').
This is to inform that Company has received request from following member of 'Promoter Group' requesting the Company to re-classify them from 'Promoter Group Category' to 'Public Category' in accordance with Regulation 31A of Listing Regulations.23-07-2021
Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform you that Conference Call for the Investors and Analysts has been scheduled on Wednesday, July 28, 2021 at 3:30 PM IST to discuss the Company's financial performance for the Quarter ended June 30, 2021.23-07-2021
AARTI DRUGS LTD. - 524348 - Board Meeting Intimation for Board Meeting
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2021 ,inter alia, to consider and approve This is to inform you that next Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, July 27, 2021 to consider, approve and take on record Audited Financial Results for the Quarter ended June 30, 2021.20-07-2021
Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Demise
Intimation of sad demise of Independent Director of the Company17-07-2021
Aarti Drugs Ltd - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates16-07-2021
AARTI DRUGS LTD. - 524348 - Shareholding for the Period Ended June 30, 2021
Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here07-07-2021